These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1388841)

  • 1. Antigen presentation in virus infection.
    Murray N; McMichael A
    Curr Opin Immunol; 1992 Aug; 4(4):401-7. PubMed ID: 1388841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
    Hosken NA; Bevan MJ
    J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective presentation of endogenous antigen by a cell line expressing class I molecules.
    Hosken NA; Bevan MJ
    Science; 1990 Apr; 248(4953):367-70. PubMed ID: 2326647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-restricted recognition of viral antigens in HLA transgenic mice.
    Kievits F; Ivanyi P; Krimpenfort P; Berns A; Ploegh HL
    Nature; 1987 Oct 1-7; 329(6138):447-9. PubMed ID: 2821399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer.
    Spies T; Cerundolo V; Colonna M; Cresswell P; Townsend A; DeMars R
    Nature; 1992 Feb; 355(6361):644-6. PubMed ID: 1538752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum.
    Cox JH; Yewdell JW; Eisenlohr LC; Johnson PR; Bennink JR
    Science; 1990 Feb; 247(4943):715-8. PubMed ID: 2137259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
    Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
    J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
    Melief CJ; Boog CJ; Vasmel WL; Boes J; Voordouw AC; Kast WM
    Ann N Y Acad Sci; 1988; 532():280-91. PubMed ID: 2845847
    [No Abstract]   [Full Text] [Related]  

  • 18. Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.
    Raafat N; Sadowski-Cron C; Mengus C; Heberer M; Spagnoli GC; Zajac P
    Int J Cancer; 2012 Sep; 131(5):E659-69. PubMed ID: 22116674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.
    Morita D; Sugita M
    Immunology; 2016 Oct; 149(2):139-45. PubMed ID: 27402593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the cytotoxic T cell epitopes of mouse hepatitis virus, using elution of viral peptides from class I MHC molecules as an approach.
    Heemskerk MH; Schoemaker HM; Alphen HE; van der Zee R; Joosten I; Spaan WJ; Boog CJ
    Adv Exp Med Biol; 1993; 342():407-12. PubMed ID: 7516109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.